All lobbying filings

THE NICKLES GROUP, LLC

THE NICKLES GROUP, LLC filed a Q2 report for OMEROS CORPORATION on July 14, 2025, reporting $40,000 in lobbying income.

Lobbying for OMEROS CORPORATION · Biopharmaceutical company.

All filings by THE NICKLES GROUP, LLC · Everything OMEROS CORPORATION has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 14, 2025

Income

$40,000

What the client paid this registrant for the period.

Client based in

Washington

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Monitored separate payment policy for nonopioid alternatives. Issues involving rare disease therapies.

Health Issues

Monitored issues related to rare pediatric disease and Priority Review Vouchers (PRVs).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.